Embody vs Henry Meds: Which GLP: 2026 Pricing and Plans Compared

Last reviewed: September 2, 2026 Last updated: September 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

If you prefer month-to-month flexibility and a 6-month money-back guarantee, Embody offers injectable semaglutide at $299/month and injectable tirzepatide at $349/month, both with unlimited provider visits and 24/7 clinical chat. If you want oral semaglutide or plan to commit to 6 or 12 months for a lower rate, Henry Meds offers injectable semaglutide at $297/month month-to-month or $247/month prepaid for six months, plus oral semaglutide at $249/month and oral tirzepatide (though Henry's own product page states the tirzepatide term inconsistently—confirm at checkout). Neither provider offers injectable tirzepatide; Henry Meds offers oral tirzepatide only. If you want the lowest ongoing injectable rate and optional genetics, PlexusDx offers injectable semaglutide at $189/month month-to-month or $149/month prepaid for six months, and injectable tirzepatide at $289/month month-to-month or $249/month prepaid for six months—$1,296 to $1,320 less per year than Embody or Henry Meds on injectable semaglutide at standard month-to-month rates, and $1,176 less per year than Henry Meds on six-month prepaid semaglutide. All three providers bundle the provider visit, medication, and shipping into the monthly price with no separate membership fee.

At-a-glance comparison

All prices verified September 2, 2026. MTM = month-to-month.

Normalized pricing: 12-month cost by compound and plan type

The most direct like-for-like comparison is month-to-month injectable semaglutide. We calculate 12-month totals by multiplying the monthly rate by twelve; these are our calculations to normalize billing cadence, not quotes from the providers.

Injectable semaglutide, month-to-month

• PlexusDx: $189/month × 12 = $2,268/year
• Henry Meds: $297/month × 12 = $3,564/year
• Embody: $299/month × 12 = $3,588/year

Difference: PlexusDx saves $1,296 per year versus Henry Meds and $1,320 per year versus Embody at standard month-to-month rates.

Injectable semaglutide, 6-month prepaid

PlexusDx and Henry Meds both offer 6-month prepaid plans; Embody does not. Per-month equivalents are prepaid totals divided by six; 12-month totals are twice the 6-month prepaid amount (our calculation).

• PlexusDx: $149/month (prepaid) = $894 for 6 months → $894 × 2 = $1,788/year
• Henry Meds: $247/month (prepaid) = $1,482 for 6 months → $1,482 × 2 = $2,964/year
• Embody: No 6-month plan published

Difference: PlexusDx saves $1,176 per year versus Henry Meds on six-month prepaid injectable semaglutide.

Henry Meds 12-month prepaid semaglutide (no like-for-like comparison)

Henry Meds offers a 12-month prepaid plan at $197/month ($2,364 paid upfront). PlexusDx and Embody do not offer 12-month plans, so this is not a like-for-like comparison. Henry's deepest rate requires a year paid in full and obligates you to the remaining balance unless a provider determines you cannot continue for medical reasons.

Injectable tirzepatide, month-to-month

• PlexusDx: $289/month × 12 = $3,468/year
• Embody: $349/month × 12 = $4,188/year
• Henry Meds: Injectable tirzepatide not offered (oral tirzepatide only)

Difference: PlexusDx saves $720 per year versus Embody. Henry Meds does not offer injectable tirzepatide.

Oral semaglutide, month-to-month

• Henry Meds: $249/month × 12 = $2,988/year
• PlexusDx: $289/month × 12 = $3,468/year
• Embody: Not offered

Difference: Henry Meds saves $480 per year versus PlexusDx on oral semaglutide.

Decision factors beyond price

Embody strengths

• 6-month money-back guarantee: Embody offers a money-back guarantee; we captured the headline but not the full terms, so confirm the conditions before enrollment.
• 24/7 clinical chat support: Real-time messaging with clinical staff may suit users who want immediate answers outside business hours.
• Unlimited provider visits included: No visit caps or per-consultation fees.
• Month-to-month only: No multi-month lock-in, though this also means Embody does not offer lower committed-term rates.

Embody gaps

• No oral formulations of semaglutide or tirzepatide.
• No multi-month prepaid option to reduce per-month cost.
• Injectable semaglutide costs $110/month more than PlexusDx month-to-month, $150/month more than PlexusDx six-month prepaid.
• Injectable tirzepatide costs $60/month more than PlexusDx month-to-month.
• No genetics add-on for metabolic personalization.

Henry Meds strengths

• Oral semaglutide at $249/month: The lowest oral semaglutide rate among the three providers, $40/month less than PlexusDx.
• Broadest formulation menu: Injectable and oral semaglutide, oral tirzepatide, oral microdose semaglutide, and phentermine (tirzepatide injectable not offered).
• Lower committed-term rates: Six-month prepaid semaglutide at $247/month and 12-month prepaid at $197/month offer deeper rates than Embody (though PlexusDx six-month prepaid is $149/month).
• Works with both 503A pharmacies and outsourcing facilities: May offer supply continuity during shortages, though this also means formulations may vary by facility type.

Henry Meds gaps

• No injectable tirzepatide (oral tirzepatide only).
• Oral tirzepatide product page states the term inconsistently—heading says 3-month supply, body text says six months—so confirm the term and total at checkout.
• Prepaid plans require you to pay the remaining balance if you cancel, unless a provider determines a medical reason prevents continuation.
• Injectable semaglutide month-to-month costs $108/month more than PlexusDx; six-month prepaid costs $98/month more than PlexusDx.
• No genetics add-on.

PlexusDx strengths

• Lowest injectable semaglutide rates: $189/month month-to-month, $169/month three-month, $149/month six-month—$1,296 to $1,320 less per year than Embody or Henry Meds at standard month-to-month rates, $1,176 less per year than Henry Meds six-month prepaid.
• Lowest injectable tirzepatide rates: $289/month month-to-month, $269/month three-month, $249/month six-month—$720 less per year than Embody month-to-month. Henry Meds does not offer injectable tirzepatide.
• Genetics add-on available: $298 standalone, $99 for program members—metabolic insights no other provider in this comparison offers.
• Free one-on-one check-in with Dr. Jayden Lee, PharmD: Personalized pharmacist consultation included.
• Broadest injectable menu: Semaglutide and tirzepatide injectable, plus oral semaglutide, oral tirzepatide, and microdose GLP-1 at $129/month.
• Three billing cadences: Month-to-month, 3-month, and 6-month prepaid options for most compounds.

PlexusDx gaps

• Oral semaglutide costs $40/month more than Henry Meds month-to-month.
• No 24/7 live chat (support via email and scheduled consultations).
• No money-back guarantee.

Choose Embody if…

• You want a 6-month money-back guarantee and are willing to pay $110 to $150/month more than PlexusDx for that assurance.
• 24/7 clinical chat is a priority and you prefer real-time text support over scheduled calls or email.
• You prefer month-to-month billing and are comfortable with Embody's higher ongoing rate in exchange for unlimited provider visits and the money-back policy.
• You plan to use injectable semaglutide or injectable tirzepatide and do not need oral formulations or genetics.

Choose Henry Meds if…

• You want oral semaglutide at the lowest rate among the three providers ($249/month, $40 less than PlexusDx).
• You prefer an oral tirzepatide formulation over injectable (though confirm the term at checkout due to the product-page inconsistency) or want access to microdose semaglutide or phentermine.
• You are willing to commit to six months ($247/month semaglutide, $1,482 prepaid) or twelve months ($197/month semaglutide, $2,364 prepaid) for lower per-month rates than Embody, understanding that cancellation requires paying the remaining balance unless a provider determines a medical reason.
• You do not need injectable tirzepatide and prioritize formulation variety over the lowest injectable rate.

Choose PlexusDx if…

• You want the lowest ongoing injectable semaglutide rate—$189/month month-to-month, $149/month six-month prepaid—saving $1,176 to $1,320 per year versus the other two providers' standard or prepaid rates.
• You want injectable tirzepatide at $289/month month-to-month or $249/month six-month prepaid, $720/year less than Embody and unavailable at Henry Meds.
• You value metabolic genetics and want the option to add genomic insights ($99 for program members) that neither Embody nor Henry Meds offers.
• You prefer a free one-on-one pharmacist check-in over 24/7 chat and are comfortable with email and scheduled support.
• You want the flexibility to choose month-to-month, 3-month, or 6-month billing across injectable and oral semaglutide, injectable and oral tirzepatide, and microdose GLP-1.

Methodology and freshness

We captured Embody's month-to-month injectable semaglutide and tirzepatide pricing, inclusions, and cancellation terms from Embody's published rates on September 2, 2026. We captured Henry Meds' month-to-month and prepaid rates for injectable semaglutide, oral semaglutide, and formulation availability from Henry Meds' published pricing and product pages on September 2, 2026. Henry Meds' oral tirzepatide product page states the term inconsistently (3-month supply in the heading, six months in the body text); we recommend confirming the term and total at checkout. PlexusDx pricing is our own published rates, verified September 2, 2026. All 12-month cost calculations are our arithmetic (monthly rate × 12 or prepaid total × 2) to normalize billing cadence and are not direct quotes from the providers. We describe prepaid figures as per-month equivalents where applicable. We use standard ongoing rates and prepaid totals only, verified at the dates shown. Committed-term rates are labeled as prepaid. We do not publish conditional figures; Henry Meds' microdose semaglutide page states "starts at $179/month," which appears conditional, so we exclude that figure and note only that Henry offers microdose semaglutide. We worked with the evidence available on September 2, 2026; confirm current pricing, term lengths, and guarantee conditions at each provider's checkout before enrollment.

Frequently Asked Questions

Does Embody or Henry Meds offer tirzepatide injection?

Embody offers injectable tirzepatide at $349/month month-to-month. Henry Meds does not offer injectable tirzepatide; Henry offers oral tirzepatide only, prepaid on a term its product page states inconsistently, so confirm the term at checkout. PlexusDx offers injectable tirzepatide at $289/month month-to-month or $249/month six-month prepaid.

Which provider has the lowest injectable semaglutide rate?

PlexusDx has the lowest injectable semaglutide rate at $189/month month-to-month or $149/month six-month prepaid, verified September 2, 2026. Embody charges $299/month month-to-month with no multi-month option. Henry Meds charges $297/month month-to-month or $247/month six-month prepaid. PlexusDx saves $1,296 to $1,320 per year versus Embody or Henry Meds at standard month-to-month rates, and $1,176 per year versus Henry Meds six-month prepaid (our 12-month calculations).

Can I cancel a prepaid plan at Henry Meds without penalty?

Henry Meds states you may cancel at any time via your account page, email, or phone. However, if you are on a multi-month plan, you may be required to pay the remaining balance unless you are unable to continue for medical-related reasons as determined by a healthcare provider, verified September 2, 2026. Embody and PlexusDx month-to-month plans allow cancel-anytime with no balance obligation.

Does any provider offer a money-back guarantee?

Embody offers a 6-month money-back guarantee, verified September 2, 2026. We captured the headline but not the full terms, so confirm the conditions and any exclusions before enrollment. Henry Meds and PlexusDx do not offer money-back guarantees as of September 2, 2026.

Which provider offers the most formulation options?

Henry Meds offers the broadest formulation menu: injectable semaglutide, oral semaglutide, oral tirzepatide, oral microdose semaglutide, and phentermine, verified September 2, 2026. Henry does not offer injectable tirzepatide. PlexusDx offers injectable semaglutide, injectable tirzepatide, oral semaglutide, oral tirzepatide, and microdose GLP-1. Embody offers injectable semaglutide and injectable tirzepatide only, with no oral formulations.

Sources

• Embody published pricing and program details (captured September 2, 2026)
• Henry Meds published pricing, product pages, and program details (captured September 2, 2026)
• PlexusDx published pricing and program details (captured September 2, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.